Back to Trades
Total Value
$174.2K
Net $174.2K sold
Filing Date
Sep 26, 2025
2 transactions
Sales
$174.2K
2 transactions
Trade Summary
On Sep 24, 2025 through Sep 25, 2025, Szot Matthew K, Chief Financial Officer, sold $174.2K of Cadrenal Therapeutics, Inc. (CVKD) across 2 transactions. The filing covers Common Stock and reflects net selling of $174.2K. Reported prices ranged from $14.00 to $14.05. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cadrenal Therapeutics, Inc.
- Ticker Symbol
- CVKD
- CIK
- 0001937993
Insider Information
- Name
- Szot Matthew K
- Role
- Chief Financial Officer
- Location
- PONTE VEDRA, FL
Filing Details
- Filing Date
- Sep 26, 2025
- Transaction Date
- Sep 24, 2025
- Accession Number
- 0001213900-25-092558
- Form Type
- 4
- Net Trading Amount
- -$174.2K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 24, 2025 | Common Stock | 1,500 | $14.00 | Sale | $21.0K |
| Sep 25, 2025 | Common Stock | 10,900 | $14.05 | Sale | $153.2K |
Want live alerts when Szot Matthew K trades again?
Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.02, inclusive, having a weighted average price as shown in column 4 of $13.9953. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F2)Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.52, inclusive, having a weighted average price as shown in column 4 of $14.0534. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.